Patients who overdose on tirzepatide should be monitored for any changes in clinical status. As this medication has a long half-life, patients may require prolonged monitoring. Clinicians should contact poison control, and consultation with a toxicologist may be necessary. There is no current antidote for tirzepatide overdose, but supportive care for symptom control would be consistent with the usual standard of care.

Patients with acute pancreatitis usually present with abdominal pain, serum lipase>3 ULN, and evidence of acute pancreatitis on imaging. American Gastroenterological Association guidelinesÂ recommend goal-directed fluid management for patients with acute pancreatitis.